Humana (NYSE:HUM) Hits New 52-Week Low – What’s Next?

Humana Inc. (NYSE:HUM)’s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as $189.19 and last traded at $191.7450, with a volume of 79852 shares. The stock had previously closed at $195.20.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. KeyCorp restated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Truist Financial dropped their price target on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Wells Fargo & Company downgraded Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Morgan Stanley restated an “underperform” rating on shares of Humana in a report on Thursday, December 18th. Finally, Zacks Research lowered Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $293.21.

Humana Stock Performance

The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $22.99 billion, a price-to-earnings ratio of 17.93, a price-to-earnings-growth ratio of 1.61 and a beta of 0.44. The firm’s fifty day moving average price is $256.45 and its 200 day moving average price is $264.29.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. During the same period in the prior year, the firm earned $4.16 earnings per share. The firm’s revenue was up 11.1% compared to the same quarter last year. Analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Institutional Trading of Humana

A number of large investors have recently modified their holdings of the stock. PFA Pension Forsikringsaktieselskab purchased a new stake in Humana during the 4th quarter worth about $9,013,000. Horizon Investments LLC lifted its stake in Humana by 2.5% in the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after acquiring an additional 55 shares during the last quarter. Danske Bank A S increased its position in shares of Humana by 87.4% in the 4th quarter. Danske Bank A S now owns 108,319 shares of the insurance provider’s stock valued at $27,744,000 after purchasing an additional 50,509 shares during the last quarter. Cullinan Associates Inc. lifted its position in shares of Humana by 4.9% during the 4th quarter. Cullinan Associates Inc. now owns 1,600 shares of the insurance provider’s stock worth $410,000 after purchasing an additional 75 shares during the last quarter. Finally, New York State Teachers Retirement System grew its stake in shares of Humana by 1.4% during the fourth quarter. New York State Teachers Retirement System now owns 93,651 shares of the insurance provider’s stock worth $23,987,000 after purchasing an additional 1,336 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.